1145 related articles for article (PubMed ID: 19644042)
1. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
[TBL] [Abstract][Full Text] [Related]
3. Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors.
Masuko T; Nemoto Y; Nagaoka H; Miyake M; Kizawa Y; Kusama-Eguchi K; Kashiwagi K; Igarashi K; Kusama T
Neuropharmacology; 2007 Sep; 53(4):515-23. PubMed ID: 17681353
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
[TBL] [Abstract][Full Text] [Related]
5. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
6. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons.
Yang XC; Reis DJ
J Pharmacol Exp Ther; 1999 Feb; 288(2):544-9. PubMed ID: 9918557
[TBL] [Abstract][Full Text] [Related]
7. Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.
Igarashi K; Shirahata A; Pahk AJ; Kashiwagi K; Williams K
J Pharmacol Exp Ther; 1997 Nov; 283(2):533-40. PubMed ID: 9353367
[TBL] [Abstract][Full Text] [Related]
8. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
[TBL] [Abstract][Full Text] [Related]
9. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
10. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
Igarashi K; Williams K
J Pharmacol Exp Ther; 1995 Mar; 272(3):1101-9. PubMed ID: 7891322
[TBL] [Abstract][Full Text] [Related]
11. Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance.
Rock DM; MacDonald RL
Mol Pharmacol; 1992 Jul; 42(1):157-64. PubMed ID: 1378923
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity.
Akasofu S; Kimura M; Kosasa T; Ogura H; Sawada K
Eur J Pharmacol; 2006 Jan; 530(3):215-22. PubMed ID: 16406045
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.
Williams K; Dattilo M; Sabado TN; Kashiwagi K; Igarashi K
J Pharmacol Exp Ther; 2003 May; 305(2):740-8. PubMed ID: 12606689
[TBL] [Abstract][Full Text] [Related]
14. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
Williams K; Zappia AM; Pritchett DB; Shen YM; Molinoff PB
Mol Pharmacol; 1994 May; 45(5):803-9. PubMed ID: 8190097
[TBL] [Abstract][Full Text] [Related]
17. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors.
Chao J; Seiler N; Renault J; Kashiwagi K; Masuko T; Igarashi K; Williams K
Mol Pharmacol; 1997 May; 51(5):861-71. PubMed ID: 9145925
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
Sharma TA; Reynolds IJ
J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
[TBL] [Abstract][Full Text] [Related]
19. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A
Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]